210 related articles for article (PubMed ID: 18383175)
1. Risk of nonmelanoma skin cancer with azathioprine use.
Maddox JS; Soltani K
Inflamm Bowel Dis; 2008 Oct; 14(10):1425-31. PubMed ID: 18383175
[TBL] [Abstract][Full Text] [Related]
2. Nonmelanoma skin cancer in inflammatory bowel disease: a review.
Long MD; Kappelman MD; Pipkin CA
Inflamm Bowel Dis; 2011 Jun; 17(6):1423-7. PubMed ID: 21053358
[TBL] [Abstract][Full Text] [Related]
3. Azathioprine, UV light, and skin cancer in organ transplant patients--do we have an answer?
Ulrich C; Stockfleth E
Nephrol Dial Transplant; 2007 Apr; 22(4):1027-9. PubMed ID: 17234668
[No Abstract] [Full Text] [Related]
4. Risk of merkel cell carcinoma after solid organ transplantation.
Clarke CA; Robbins HA; Tatalovich Z; Lynch CF; Pawlish KS; Finch JL; Hernandez BY; Fraumeni JF; Madeleine MM; Engels EA
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25575645
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease, azathioprine and skin cancer: case report and literature review.
Austin AS; Spiller RC
Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):193-4. PubMed ID: 11246621
[TBL] [Abstract][Full Text] [Related]
6. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients.
Ulrich C; Schmook T; Sachse MM; Sterry W; Stockfleth E
Dermatol Surg; 2004 Apr; 30(4 Pt 2):622-7. PubMed ID: 15061846
[TBL] [Abstract][Full Text] [Related]
7. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
Peyrin-Biroulet L; Khosrotehrani K; Carrat F; Bouvier AM; Chevaux JB; Simon T; Carbonnel F; Colombel JF; Dupas JL; Godeberge P; Hugot JP; Lémann M; Nahon S; Sabaté JM; Tucat G; Beaugerie L;
Gastroenterology; 2011 Nov; 141(5):1621-28.e1-5. PubMed ID: 21708105
[TBL] [Abstract][Full Text] [Related]
8. A review of heart transplant immunosuppressants and nonmelanoma skin cancer.
Eckembrecher DG; Eckembrecher FJ; Camacho I; Shah H; Dave Y; Patel S; Nouri K
Arch Dermatol Res; 2023 Nov; 315(9):2491-2503. PubMed ID: 37256379
[TBL] [Abstract][Full Text] [Related]
9. Nonmelanoma skin cancer risk awareness in azathioprine-treated myasthenia gravis patients.
McGurgan IJ; McGuigan C
Brain Behav; 2015 Oct; 5(10):e00396. PubMed ID: 26516615
[TBL] [Abstract][Full Text] [Related]
10. [Ki-1 lymphoma of the skin in a patient with Crohn's disease undergoing treatment with azathioprine].
Martínez Tirado P; Redondo Cerezo E; Gónzalez Aranda Y; J Cabello Tapia M; Nogueras López F; Gómez García M
Gastroenterol Hepatol; 2001 May; 24(5):271-2. PubMed ID: 11412602
[No Abstract] [Full Text] [Related]
11. Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the Literature.
Hagen JW; Pugliano-Mauro MA
Dermatol Surg; 2018 Apr; 44(4):469-480. PubMed ID: 29315147
[TBL] [Abstract][Full Text] [Related]
12. Level of UV Exposure, Skin Type, and Age Are More Important than Thiopurine Use for Keratinocyte Carcinoma Development in IBD Patients.
Wu Y; Ghaly S; Kerr S; Jackson B; Hanigan K; Martins D; Krishnaprasad K; Mountifield RE; Whiteman DC; Bampton PA; Gearry RB; Radford-Smith GL; Lawrance IC
Dig Dis Sci; 2020 Apr; 65(4):1172-1179. PubMed ID: 31493039
[TBL] [Abstract][Full Text] [Related]
13. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous malignancies in immunosuppressed organ transplant recipients.
Seda IM; Zubair A; Brewer JD
Skinmed; 2014; 12(3):164-73. PubMed ID: 25134313
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression, skin cancer, and ultraviolet A radiation.
Parrish JA
N Engl J Med; 2005 Dec; 353(25):2712-3. PubMed ID: 16371639
[No Abstract] [Full Text] [Related]
16. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.
Mudigonda T; Levender MM; O'Neill JL; West CE; Pearce DJ; Feldman SR
Dermatol Surg; 2013 Mar; 39(3 Pt 1):345-64. PubMed ID: 23190408
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease].
Kim JH; Kim JW
Korean J Gastroenterol; 2017 Oct; 70(4):162-168. PubMed ID: 29060953
[TBL] [Abstract][Full Text] [Related]
18. Genetics and nonmelanoma skin cancer in kidney transplant recipients.
Burke MT; Isbel N; Barraclough KA; Jung JW; Wells JW; Staatz CE
Pharmacogenomics; 2015 Jan; 16(2):161-72. PubMed ID: 25616102
[TBL] [Abstract][Full Text] [Related]
19. Management of non-melanoma skin cancer in solid organ transplant recipients.
Specchio F; Saraceno R; Chimenti S; Nistico S
Int J Immunopathol Pharmacol; 2014; 27(1):21-4. PubMed ID: 24674675
[TBL] [Abstract][Full Text] [Related]
20. More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine.
de Graaf YG; Rebel H; Elghalbzouri A; Cramers P; Nellen RG; Willemze R; Bouwes Bavinck JN; de Gruijl FR
Exp Dermatol; 2008 Apr; 17(4):349-55. PubMed ID: 17979968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
